Search - tctmd.com

Displaying 361 - 380 of 509

Sort: Relevancy | Date

News Industry News

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

June 27, 2016

News Conference News TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Shelley Wood

June 20, 2016

Presentation TVT 2016

TVT 1130: Transcatheter Aortic Valve Implantation in a Heart-Failure Patient With a Left Ventricular Assist Device and Severe Aortic Regurgitation

Presenter: Frank van der kley, MD

June 17, 2016

Presentation TVT 2016

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

Presenter: Nicolas M. Van Mieghem

June 17, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Industry News

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

May 16, 2016

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

News Industry News

First Patients in Central Pennsylvania Received New Aortic Valve Reconstruction Procedures at PinnacleHealth

May 03, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Daily News

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Michael O'Riordan

April 18, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Daily News

FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock

Michael O'Riordan

April 08, 2016

Advertisement

BioVentrix Receives CE Marking Certification for Revivent TC™, the First Minimally Invasive Heart Failure Treatment to Restore the Left Ventricle

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

TVT 1130: Transcatheter Aortic Valve Implantation in a Heart-Failure Patient With a Left Ventricular Assist Device and Severe Aortic Regurgitation

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

First Patients in Central Pennsylvania Received New Aortic Valve Reconstruction Procedures at PinnacleHealth

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

A-fib Post-TAVR Associated With Increased Risk of Mortality, Bleeding

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content